We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.80 | 1.63% | 50.03 | 50.03 | 50.20 | 50.37 | 48.85 | 49.17 | 1,363,472 | 00:58:44 |
From May 2019 to May 2024
--Canopy Growth Corp., the world's biggest producer of cannabis by market value, is bidding for Spain's Alcaliber SA in a deal that may see the latter valued at EUR200 million to EUR275 million, Bloomberg says, citing unnamed sources.
--Ontario-based Canopy is facing off against U.K. health-care investor GHO Capital and Spanish investment firm Alantra Partners SA, with final bids set to be tendered in the comings days, reports Bloomberg.
--According to Bloomberg, Alcaliber, which produces morphine and thebaine, is majority-owned by Spanish investment fund Torreal SA, with French drug maker Sanofi holding a 40% stake.
Full story: https://bloom.bg/2FtyLKY
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
March 06, 2018 09:08 ET (14:08 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
